lysophosphatidylethanolamine (22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)

Term ID

CHEBI:72747

Synonyms

(2R)-3-{[(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-hydroxypropyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate
LPE 22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0
LPE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
Lyso-PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
LysoPE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
PE 22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)

Definition

A 1-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as 4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: 1-acyl-sn-glycero-3-phosphoethanolamine lysophosphatidylethanolamine 22:6

1-acyl-sn-glycero-3-phosphoethanolamine lysophosphatidylethanolamine 22:6 Show first 5 Terms
has_functional_parent: all-cis-docosa-4,7,10,13,16,19-hexaenoic acid

all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Show first 5 Terms
has_role: metabolite

metabolite Show first 5 Terms

Phenotype

Phenotype resulting from lysophosphatidylethanolamine (22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)

Phenotype where environments contain lysophosphatidylethanolamine (22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)

Phenotype modified by environments containing lysophosphatidylethanolamine (22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)

Human Disease Model